COURTNEY DAVIS: Open Payments
NPI 1790406528 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 24 payments from 7 companies in 2025. Trend: 2023 $41 · 2024 $652 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $206 |
| Vanda Pharmaceuticals Inc. | 7 | $196 |
| ABBVIE INC. | 1 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: CAPLYTA, FANAPT, VRAYLAR, BREZTRI, Natroba, Auvelity, ZEPBOUND, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
